Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date

por weekers, LE, Campistol, JM, Espinosa, M, Gaber, AO, Menne, J, Minetti, E, Provot, F, Rondeau, E, Ogawa, M, Bedrosian, CL, hourmant, M
Publicado 2014

Elevated soluble Flt1 mediates an anti-angiogenic state in patients with ANCA-associated vasculitis

por Le Roux, S, Pepper, R, Dufay, A, Néel, M, Lamandé, N, Rimbert, M, Josien, R, Hamidou, M, Hourmant, M, Cook, H T, Charreau, B, Larger, E, Salama, A, Fakhouri, F
Publicado 2010